Leptin induces nitric oxide-mediated inhibition of lipolysis and glyceroneogenesis in rat white adipose tissue1-3

Journal of Nutrition

Volumn 141, Issue 1, 2011, Pages 4-9

  Niang, Fatoumata ^a   Benelli, Chantal ^a   Ribiére, Catherine ^a   Collinet, Martine ^a   Mehebik Mojaat, Nadia ^a   Penot, Graziella ^a   Forest, Claude ^a   Jaubert, Anne Marie ^b  

^a INSERM   (France)

^b LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 14; FATTY ACID; GLYCEROL; HORMONE SENSITIVE LIPASE; LEPTIN; MESSENGER RNA; N ACETYL S NITROSOPENICILLAMINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE INHIBITOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHOENOLPYRUVATE CARBOXYKINASE (ATP); PYRUVIC ACID; TRIACYLGLYCEROL;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOWN REGULATION; ESTERIFICATION; FATTY ACID OXIDATION; GENE EXPRESSION; HYPERTRIGLYCERIDEMIA; INHIBITION KINETICS; LIPOLYSIS; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; RECEPTOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE, WHITE; ANIMALS; FATTY ACIDS, NONESTERIFIED; GLYCEROL; LEPTIN; LIPOLYSIS; MALE; NITRIC OXIDE; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 78650484335     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.110.125765     Document Type: Article

References (43)

1. Friedman JM. Leptin, leptin receptors, and the control of body weight. Nutr Rev. 1998;56:s38-46; discussion s54-75.
2. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, et al. Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med. 1995;1:1155-61.
3. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 1996;334:292-5.
4. Robertson SA, Leinninger GM, Myers MG Jr. Molecular and neural mediators of leptin action. Physiol Behav. 2008;94:637-42.
5. Irani BG, Le Foll C, Dunn-Meynell A, Levin BE. Effects of leptin on rat ventromedial hypothalamic neurons. Endocrinology. 2008;149:5146-54.
6. Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, Richards GJ, Campfield LA, Clark FT, et al. Identification and expression cloning of a leptin receptor, OB-R. Cell. 1995;83:1263-71.
7. Siegrist-Kaiser CA, Pauli V, Juge-Aubry CE, Boss O, Pernin A, ChinWW, Cusin I, Rohner-Jeanrenaud F, Burger AG, et al. Direct effects of leptin on brown and white adipose tissue. J Clin Invest. 1997;100:2858-64.
8. Machinal-Quelin F, Dieudonne MN, Leneveu MC, Pecquery R, Giudicelli Y. Proadipogenic effect of leptin on rat preadipocytes in vitro: Activation of MAPK and STAT3 signaling pathways. Am J Physiol Cell Physiol. 2002;282:C853-63.
9. Wang MY, Lee Y, Unger RH. Novel form of lipolysis induced by leptin. J Biol Chem. 1999;274:17541-4.
10. Bai Y, Zhang S, Kim KS, Lee JK, Kim KH. Obese gene expression alters the ability of 30A5 preadipocytes to respond to lipogenic hormones. J Biol Chem. 1996;271:13939-42.
11. Zhou YT, Wang ZW, Higa M, Newgard CB, Unger RH. Reversing adipocyte differentiation: Implications for treatment of obesity. Proc Natl Acad Sci USA. 1999;96:2391-5.
12. Fruhbeck G, Aguado M, Martinez JA. In vitro lipolytic effect of leptin on mouse adipocytes: Evidence for a possible autocrine/paracrine role of leptin. Biochem Biophys Res Commun. 1997;240:590-4.
13. Fruhbeck G, Aguado M, Gomez-Ambrosi J, Martinez JA. Lipolytic effect of in vivo leptin administration on adipocytes of lean and ob/ob mice, but not db/db mice. Biochem Biophys Res Commun. 1998;250: 99-102.
14. Gaudiot N, Jaubert AM, Charbonnier E, Sabourault D, Lacasa D, Giudicelli Y, Ribiere C. Modulation of white adipose tissue lipolysis by nitric oxide. J Biol Chem. 1998;273:13475-81.
15. Fruhbeck G, Gomez-Ambrosi J. Modulation of the leptin-induced white adipose tissue lipolysis by nitric oxide. Cell Signal. 2001;13:827-33.
16. Mehebik N, Jaubert AM, Sabourault D, Giudicelli Y, Ribiere C. Leptininduced nitric oxide production in white adipocytes is mediated through PKA and MAP kinase activation. Am J Physiol Cell Physiol. 2005;289: C379-87.
17. Vaughan M. The production and release of glycerol by adipose tissue incubated in vitro. J Biol Chem. 1962;237:3354-8.
18. Ballard FJ, Hanson RW, Leveille GA. Phosphoenolpyruvate carboxykinase and the synthesis of glyceride-glycerol from pyruvate in adipose tissue. J Biol Chem. 1967;242:2746-50.
19. Reshef L, Hanson RW, Ballard FJ. A possible physiological role for glyceroneogenesis in rat adipose tissue. J Biol Chem. 1970;245: 5979-84.
20. Tordjman J, Chauvet G, Quette J, Beale EG, Forest C, Antoine B. Thiazolidinediones block fatty acid release by inducing glyceroneogenesis in fat cells. J Biol Chem. 2003;278:18785-90.
21. Leroyer SN, Tordjman J, Chauvet G, Quette J, Chapron C, Forest C, Antoine B. Rosiglitazone controls fatty acid cycling in human adipose tissue by means of glyceroneogenesis and glycerol phosphorylation. J Biol Chem. 2006;281:13141-9.
22. Cadoudal T, Blouin JM, Collinet M, Fouque F, Tan GD, Loizon E, Beale EG, Frayn KN, Karpe F, et al. Acute and selective regulation of glyceroneogenesis and cytosolic phosphoenolpyruvate carboxykinase in adipose tissue by thiazolidinediones in type 2 diabetes. Diabetologia. 2007;50:666-75.
23. Franckhauser S, Munoz S, Pujol A, Casellas A, Riu E, Otaegui P, Su B, Bosch F. Increased fatty acid re-esterification by PEPCK overexpression in adipose tissue leads to obesity without insulin resistance. Diabetes. 2002;51:624-30.
24. Olswang Y, Cohen H, Papo O, Cassuto H, Croniger C, Hakimi P, Tilghman S, Hanson R, Reshef L. A mutation in the peroxisome proliferator-activated receptor gamma-binding site in the gene for the cytosolic form of phosphoenolpyruvate carboxykinase reduces adipose tissue size and fat content in mice. Proc Natl Acad Sci USA. 2002;99: 625-30.
25. Tontonoz P, Hu E, Devine J, Beale EG, Spiegelman BM. PPAR gamma 2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene. Mol Cell Biol. 1995;15:351-7.
26. Glorian M, Duplus E, Beale EG, Scott DK, Granner DK, Forest C. A single element in the phosphoenolpyruvate carboxykinase gene mediates thiazolidinedione action specifically in adipocytes. Biochimie. 2001;83:933-43.
27. Gallardo N, Bonzon-Kulichenko E, Fernandez-Agullo T, Molto E, Gomez-Alonso S, Blanco P, Carrascosa JM, Ros M, Andres A. Tissuespecific effects of central leptin on the expression of genes involved in lipid metabolism in liver and white adipose tissue. Endocrinology. 2007; 148:5604-10.
28. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959;37:911-7.
29. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-9.
30. Servetnick DA, Brasaemle DL, Gruia-Gray J, Kimmel AR, Wolff J, Londos C. Perilipins are associated with cholesteryl ester droplets in steroidogenic adrenal cortical and Leydig cells. J Biol Chem. 1995;270: 16970-3.
31. Kawaji N, Yoshida A, Motoyashiki T, Morita T, Ueki H. Anti-leptin receptor antibody mimics the stimulation of lipolysis induced by leptin in isolated mouse fat pads. J Lipid Res. 2001;42:1671-7.
32. Khazen W, Distel E, Collinet M, Chaves VE, M'Bika JP, Chany C, Achour A, Benelli C, Forest C. Acute and selective inhibition of adipocyte glyceroneogenesis and cytosolic phosphoenolpyruvate carboxykinase by interferon gamma. Endocrinology. 2007;148:4007-14.
33. Ceddia RB, William WN Jr, Lima FB, Flandin P, Curi R, Giacobino JP. Leptin stimulates uncoupling protein-2 mRNA expression and Krebs cycle activity and inhibits lipid synthesis in isolated rat white adipocytes. Eur J Biochem. 2000;267:5952-8.
34. Deng T, Shan S, Li PP, Shen ZF, Lu XP, Cheng J, Ning ZQ. Peroxisome proliferator-activated receptor-gamma transcriptionally up-regulates hormone-sensitive lipase via the involvement of specificity protein-1. Endocrinology. 2006;147:875-84.
35. Yajima H, Kobayashi Y, Kanaya T, Horino Y. Identification of peroxisome-proliferator responsive element in the mouse HSL gene. Biochem Biophys Res Commun. 2007;352:526-31.
36. Nozaki M, Fukuhara A, Segawa K, Okuno Y, Abe M, Hosogai N, Matsuda M, Komuro R, Shimomura I. Nitric oxide dysregulates adipocytokine expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun. 2007;364:33-9.
37. Dallaire P, Bellmann K, Laplante M, Gelinas S, Centeno-Baez C, Penfornis P, Peyot ML, Latour MG, Lamontagne J, et al. Obese mice lacking inducible nitric oxide synthase are sensitized to the metabolic actions of peroxisome proliferator-activated receptor-gamma agonism. Diabetes. 2008;57:1999-2011.
38. Oral EA, Simha V, Ruiz E, Andewelt A, Premkumar A, Snell P, Wagner AJ, DePaoli AM, Reitman ML, et al. Leptin-replacement therapy for lipodystrophy. N Engl J Med. 2002;346:570-8.
39. Simha V, Szczepaniak LS, Wagner AJ, DePaoli AM, Garg A. Effect of leptin replacement on intrahepatic and intramyocellular lipid content in patients with generalized lipodystrophy. Diabetes Care. 2003;26:30-5.
40. Huang W, Dedousis N, Bandi A, Lopaschuk GD, O'Doherty RM. Liver triglyceride secretion and lipid oxidative metabolism are rapidly altered by leptin in vivo. Endocrinology. 2006;147:1480-7.
41. Huang W, Metlakunta A, Dedousis N, Ortmeyer HK, Stefanovic-Racic M, O'Doherty RM. Leptin augments the acute suppressive effects of insulin on hepatic very low-density lipoprotein production in rats. Endocrinology. 2009;150:2169-74.
42. Unger RH, Scherer PE. Gluttony, sloth and the metabolic syndrome: A roadmap to lipotoxicity. Trends Endocrinol Metab. 2010;21: 345-52.
43. Rector RS, Thyfault JP, Wei Y, Ibdah JA. Non-alcoholic fatty liver disease and the metabolic syndrome: An update. World J Gastroenterol. 2008 Jan 14;14:185-92.